Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 1998 Nov 1;18(21):8551–8558. doi: 10.1523/JNEUROSCI.18-21-08551.1998

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 1998 Society for Neuroscience

PMC Copyright notice

Fig. 5. — Potentiation of NO release induced by forskolin (FSK) and a cAMP analog. A, Potentiation of NO release induced by 50 μmforskolin (filled circles).Inset shows superposed traces recorded before application of forskolin (a), in the presence of forskolin (b), and 30 min after the cessation of forskolin application (c). Forskolin-induced potentiation in the presence of 10 μmH89 is also shown (open circles). In this experiment, slices were incubated with 10 μm H89 for at least 2 hr before and throughout the recording. B, Potentiation of NO release induced by forskolin and TS (filled circles). Inset shows tracesrecorded before application of forskolin (a), before initiation of TS (b), and 30 min after the cessation of forskolin application and TS (c). Changes in NO release elicited by application of 1,9-dideoxyforskolin (50 μm, DideoxyFSK) are also shown (open circles). C, Potentiation of NO release induced by 1 mm Br-cAMP (horizontal bar). D, Effect of 1 mm Br-cGMP (horizontal bar) on NO release.